PMV Pharmaceuticals, Inc. announced the appointment of regulatory leader, Deepika Jalota, Pharm.D. as Senior Vice President and Head of Regulatory Affairs. Prior to joining PMV Pharma, Dr. Jalota was employed by Bayer HealthCare Pharmaceuticals beginning in July 2007 and was most recently Vice President, Global Regulatory Strategy Head, Oncology I. Prior to joining Bayer, Dr. Jalota was employed with Sanofi-Aventis, Forest Laboratories and Procter and Gamble. Dr. Jalota will lead the regulatory efforts for PMV Pharma's mutant p53 restoration drug pipeline drawing upon her experience leading global regulatory strategy for both early and late stage oncology therapeutics.